|
TMEM68 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.944600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.784000E-03 |
| Normal-vs-Stage2 |
4.755400E-01 |
| Normal-vs-Stage3 |
1.112230E-01 |
| Normal-vs-Stage4 |
3.878400E-01 |
| Stage1-vs-Stage2 |
1.284780E-01 |
| Stage1-vs-Stage3 |
3.961000E-01 |
| Stage1-vs-Stage4 |
4.139200E-03 |
| Stage2-vs-Stage3 |
4.337200E-01 |
| Stage2-vs-Stage4 |
1.444430E-01 |
| Stage3-vs-Stage4 |
7.279800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.619100E-03 |
| Normal-vs-AfricanAmerican |
1.920480E-02 |
| Normal-vs-Asian |
8.083200E-01 |
| Caucasian-vs-AfricanAmerican |
7.927400E-01 |
| Caucasian-vs-Asian |
6.082600E-01 |
| AfricanAmerican-vs-Asian |
5.777200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.835400E-03 |
| Normal-vs-Female |
4.956600E-01 |
| Male-vs-Female |
3.302200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.121420E-01 |
| Normal-vs-Extreme_Weight |
3.083400E-03 |
| Normal-vs-Obese |
1.767850E-01 |
| Normal-vs-Extreme_Obese |
1.137040E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.614370E-01 |
| Normal_Weight-vs-Obese |
7.459200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.770600E-01 |
| Extreme_Weight-vs-Obese |
6.217500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.516800E-01 |
| Obese-vs-Extreme_Obese |
3.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.839600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.486300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.520100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.024200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.578400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.743900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.385900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.654600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.300200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.996800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.997600E-03 |
| Normal-VS-Type2 PRCC |
1.599800E-02 |
| Normal-VS-KIRP CIMP |
5.018500E-02 |
| Normal-VS-Unclassified PRCC |
1.015040E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.032600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.662100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.548400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.600200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.589200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.258220E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.004030E-02 |
| Normal-vs-N1 |
9.076600E-01 |
| Normal-vs-N2 |
4.411600E-01 |
| N0-vs-N1 |
2.191900E-02 |
| N0-vs-N2 |
8.018600E-03 |
| N1-vs-N2 |
3.800600E-01 |
|
|
